Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells

被引:63
作者
Kurz, DJ
Hong, Y
Trivier, E
Huang, HL
Decary, S
Zang, GH
Lüscher, TF
Erusalimsky, JD
机构
[1] UCL, BHF Labs, Cell Biol Grp, London WC1E 6JJ, England
[2] Univ Zurich, Inst Physiol, Dept Cardiovasc Res, Univ Hosp, Zurich, Switzerland
关键词
telomerase; fibroblast growth factor-2; endothelial cell; Sp1; senescence;
D O I
10.1161/01.ATV.0000069624.55424.61
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Telomerase plays a major role in the control of replicative capacity, a critical property for successful angiogenesis and maintenance of endothelial integrity. In this study, we examined the relationship between telomerase activity and endothelial cell proliferation as well as the regulation of this enzyme by fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor-A ( VEGF). Methods and Results - Telomerase was repressed in endothelial cells freshly derived from intact endothelium, whereas activity was present during logarithmic growth in culture. In cultured human umbilical vein endothelial cells (HUVECs), mRNA levels of hTERT - the catalytic subunit of telomerase - and enzyme activity decreased reversibly on induction of quiescence. Treatment of quiescent HUVECs with FGF-2 restored telomerase activity in a time- and dose-dependent manner, whereas VEGF had no such effect, although both factors induced comparable mitogenic responses. FGF-2, but not VEGF, upregulated the mRNA levels for hTERT and for the hTERT gene transactivation factor Sp1. Serial passage in the presence of individual growth factors accelerated the accumulation of senescent cells in VEGF-treated cultures compared with cultures treated with FGF-2. Conclusions - FGF-2, but not VEGF, restores telomerase activity and maintains the replicative capacity of endothelial cells.
引用
收藏
页码:748 / 754
页数:7
相关论文
共 38 条
[1]   SENESCENCE OF AORTIC ENDOTHELIAL-CELLS IN CULTURE - EFFECTS OF BASIC FIBROBLAST GROWTH-FACTOR EXPRESSION ON CELL PHENOTYPE, MIGRATION, AND PROLIFERATION [J].
AUGUSTINVOSS, HG ;
VOSS, AK ;
PAULI, BU .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 157 (02) :279-288
[2]  
BICKNELL R, 1996, ENDOTHELIAL CELL CUL, P1
[3]   Biological roles of fibroblast growth factor-2 [J].
Bikfalvi, A ;
Klein, S ;
Pintucci, G ;
Rifkin, DB .
ENDOCRINE REVIEWS, 1997, 18 (01) :26-45
[4]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[5]   Telomerase beyond telomeres [J].
Blasco, MA .
NATURE REVIEWS CANCER, 2002, 2 (08) :627-632
[6]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[7]   Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism [J].
Breitschopf, K ;
Zeiher, AM ;
Dimmeler, S .
FEBS LETTERS, 2001, 493 (01) :21-25
[8]   Cellular senescence, cancer and aging: the telomere connection [J].
Campisi, J ;
Kim, SH ;
Lim, CS ;
Rubio, M .
EXPERIMENTAL GERONTOLOGY, 2001, 36 (10) :1619-1637
[9]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[10]   Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation [J].
Dimmeler, S ;
Fleming, I ;
Fisslthaler, B ;
Hermann, C ;
Busse, R ;
Zeiher, AM .
NATURE, 1999, 399 (6736) :601-605